BRAF and thyroid tumor: The presence of TERT promoter mutations in synergy with BRAF mutations has been associated with aggressive thyroid tumor characteristics, which include lymph node metastasis, distant metastasis, tumor recurrence, multifocality, extrathyroidal extension, and patient mortality [74,75,76,77].